blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3883934

EP3883934 - THERAPEUTIC DENDRIMER [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  27.08.2021
Database last updated on 11.09.2024
FormerThe international publication has been made
Status updated on  30.05.2020
Most recent event   Tooltip21.11.2023New entry: Renewal fee paid 
Applicant(s)For all designated states
Starpharma Pty Limited
4/6 Southampton Crescent
Abbotsford VIC 3067 / AU
[2021/39]
Inventor(s)01 / OWEN, David James
c/o 4-6 Southampton Crescent
Abbotsford, Victoria 3067 / AU
02 / KELLY, Brian Devlin
c/o 4-6 Southampton Crescent
Abbotsford, Victoria 3067 / AU
03 / DIETINGER, Christine Elisabet
c/o 4-6 Southampton Crescent
Abbotsford, Victoria 3067 / AU
 [2021/39]
Representative(s)Roukounas, Dimitrios
c/o Regus Business Center
Nymphenburger Straße 4
80335 München / DE
[N/P]
Former [2021/39]Roukounas, Dimitrios
Dietlindenstraße 18
80802 München / DE
Application number, filing date19886880.420.11.2019
[2021/39]
WO2019AU51274
Priority number, dateAU2018090443120.11.2018         Original published format: AU 2018904431
AU2019090170820.05.2019         Original published format: AU 2019901708
AU2019090335810.09.2019         Original published format: AU 2019903358
[2021/39]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020102852
Date:28.05.2020
Language:EN
[2020/22]
Type: A1 Application with search report 
No.:EP3883934
Date:29.09.2021
Language:EN
The application published by WIPO in one of the EPO official languages on 28.05.2020 takes the place of the publication of the European patent application.
[2021/39]
Search report(s)International search report - published on:AU28.05.2020
(Supplementary) European search report - dispatched on:EP08.12.2022
ClassificationIPC:A61K47/64, A61K47/60, A61P35/00, C07D491/22, // A61K39/395, A61K31/4745
[2023/02]
CPC:
A61P35/00 (EP,AU,IL,KR,US); A61K31/4745 (EP,AU,IL,KR,US); C07D491/22 (EP,AU,IL,KR,US);
A61K31/502 (EP,AU,IL,KR,US); A61K39/3955 (EP,AU,IL,US); A61K45/06 (KR);
A61K47/595 (IL,KR,US); A61K47/60 (EP,KR); A61K47/641 (AU);
A61K47/645 (EP); C07K16/2803 (AU); C07K16/2818 (EP,IL,KR);
C07K16/2827 (AU); C07K16/2863 (EP,AU,IL,KR); A61K2039/505 (EP,AU,IL,KR);
A61K2300/00 (AU,IL,KR) (-)
C-Set:
A61K31/4745, A61K2300/00 (AU,EP);
A61K31/502, A61K2300/00 (AU,EP);
A61K39/3955, A61K2300/00 (AU,EP)
Former IPC [2021/39]C07D491/22, C07K16/28, A61K31/4745, A61K31/502, A61K39/395, A61K47/64, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/39]
TitleGerman:THERAPEUTISCHES DENDRIMER[2021/39]
English:THERAPEUTIC DENDRIMER[2021/39]
French:DENDRIMÈRE THÉRAPEUTIQUE[2021/39]
Entry into regional phase18.06.2021National basic fee paid 
18.06.2021Search fee paid 
18.06.2021Designation fee(s) paid 
18.06.2021Examination fee paid 
Examination procedure18.06.2021Examination requested  [2021/39]
12.07.2023Amendment by applicant (claims and/or description)
Fees paidRenewal fee
08.11.2021Renewal fee patent year 03
11.11.2022Renewal fee patent year 04
21.11.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]WO2008034120  (ENZON PHARMACEUTICALS INC [US], et al);
 [Y]US2018326081  (OWEN DAVID [AU], et al);
 [E]WO2020107078  (STARPHARMA PTY LTD [AU]);
International search[X]WO2008034120  (ENZON PHARMACEUTICALS INC [US], et al);
 [X]WO2012167309  (STARPHARMA PTY LTD [AU], et al);
 [X]US2018326081  (OWEN DAVID [AU], et al)
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.